WHAT NEWSDAY FOUND A study published this week in JAMA Psychiatry found GLP-1 drugs commonly used to treat diabetes and aid in weight loss significantly improved motivation in people with major depressive order
Current research, including data from the Womens Health Initiative (WHI), shows that risk varies based on: Type of therapy used Timing of treatment Personal health history The benefits of menopause hormone therapy may outweigh the risks if treatment is started before age 60 or within 10 years of menopause
Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness
Molecular endocrinology 27, 12341244, doi: 10.1210/me.2013-1116 (2013)
Selection: The main selection criterion will be the highest score on an abstract submitted for the CUGH annual meeting as judged routinely by the annual meeting Scientific Committee, usually at least three months before the annual meeting, which will allow time to organize sponsored travel
A meta-analysis evaluating GLP-1 RAs, including exenatide and liraglutide, found these agents more effective in reducing both SBP and DBP compared to insulin and other oral antidiabetics, providing additional cardiovascular benefits [86]
